Chemoinformaics analysis of N-(1-HYDROXY-3-PHENYLPROPAN-2-YL)BENZAMIDE
| Molecular Weight | 255.317 | nRot | 5 |
| Heavy Atom Molecular Weight | 238.181 | nRig | 26 |
| Exact Molecular Weight | 255.126 | nRing | 2 |
| Solubility: LogS | -6.088 | nHRing | 0 |
| Solubility: LogP | 7.556 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 40.7595 |
| nHD | 2 | BPOL | 18.4925 |
| QED | 0.158 |
| Synth | 5.647 |
| Natural Product Likeliness | 2.456 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.965 |
| HIA | 0.342 |
| CACO-2 | -5.08 |
| MDCK | 0.0000216 |
| BBB | 0.232 |
| PPB | 0.97568 |
| VDSS | 3.114 |
| FU | 0.0299817 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.724 |
| CYP2c19-inh | 0.234 |
| CYP2c19-sub | 0.962 |
| CYP2c9-inh | 0.225 |
| CYP2c9-sub | 0.091 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.926 |
| CYP3a4-inh | 0.401 |
| CYP3a4-sub | 0.943 |
| CL | 1.011 |
| T12 | 0.07 |
| hERG | 0.429 |
| Ames | 0.402 |
| ROA | 0.416 |
| SkinSen | 0.961 |
| Carcinogencity | 0.351 |
| EI | 0.092 |
| Respiratory | 0.819 |
| NR-Aromatase | 0.96 |
| Antiviral | No |
| Prediction | 0.675865 |